Promising CBD stocks might offer investors the next biggest play. With that in mind, Isodiol International (CSE:ISOL) (OTCQB:ISOLF) is on our radar today. Trading up 9% and selling for $1.45 CAD on the CSE, ISOL stock is reacting to news that brings Isodiol's CBD prospects to a new height.
CBD Stocks to Watch: Isodiol International
For those not in the know, you might ask: Why are CBD stocks so hot?
The answer is that CBD (cannabidiol)—extracted from both marijuana and hemp cannabis plants—can treat a myriad of ailments. These include pain, cancer, anxiety, and insomnia, but the list is ongoing as researchers are still uncovering its potential.
Because of its capabilities, CBD products have infiltrated the $4.2 trillion USD wellness market, with the US CBD market itself estimated to hit $22 billion by 2022, according to The Brightfield Group.
CBD oil and related products have proven one of the most exciting aspects of the burgeoning cannabis market and as Cannabis Pro Grower puts it:
"CBD oil has the potential to be the most widely spread cannabis product in the near future."
This brings us to Isodiol International and the ISOL CBD stock.
Isodiol CBD Stock
Headquartered in Vancouver, but with operations in the US market, Isodiol is focused on the nutritional health benefits that are derived from hemp. It has commercialized "a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nano-technology for quality consumable and topical skin care products."
>> Koios Beverage Up Over +160% After Walmart Deal Announced!
What this means to you and me is that Isodiol has developed an extra potent line of hemp-derived CBD infused products named Fast CBD Relief.
And now the CBD company has announced the launch of its 'C-Store' retail program, which will launch this range across 1,250 locations in markets such as Florida and Arizona. If all goes to plan, it will then expand up to 10,000 additional locations.
The press release states further:
"The Company will launch its Fast CBD Relief™ brand that it recently acquired with the CBD Naturals® brands portfolio as its flagship cannabinoid (CBD) products in the C-Store program."
CBD Stocks Potential
The result of this news is a 9% growth on the ISOL CBD stock at present. But if we consider the potential that these new revenue streams bring, this could mean massive stock growth in the not too distant future.
Are there other CBD stocks on your radar? Let us know below!
Featured Image: DepositPhotos © EdZbarzhyvetsky
